Header Logo

Connection

Lawrence Kushi to Breast Neoplasms

Back to Details
This is a "connection" page, showing publications Lawrence Kushi has written about Breast Neoplasms.
Lawrence Kushi
Connection Strength
14.096
Breast Neoplasms
  1. Social Support and Treatment Delays in Breast Cancer Patients Within an Integrated Health Care System. Psychooncology. 2024 Nov; 33(11):e70025.
    View in: PubMed
    Score: 0.555
  2. Clinical, Epidemiologic, and Pathologic Significance of ERBB2-Low Expression in Breast Cancer. JAMA Netw Open. 2024 Mar 04; 7(3):e243345.
    View in: PubMed
    Score: 0.530
  3. Associations of Post-Diagnosis Lifestyle with Prognosis in Women with Invasive Breast Cancer. Cancer Epidemiol Biomarkers Prev. 2023 07 05; 32(7):963-975.
    View in: PubMed
    Score: 0.506
  4. Management of ovarian and breast cancer risk in non-BRCA HBOC pathogenic variant carriers in a large California health care system. Gynecol Oncol. 2022 Dec; 167(3):467-475.
    View in: PubMed
    Score: 0.481
  5. "I Had to Make Them Feel at Ease": Narrative Accounts of How Women With Breast Cancer Navigate Social Support. Qual Health Res. 2021 05; 31(6):1056-1068.
    View in: PubMed
    Score: 0.430
  6. Personal and clinical social support and adherence to adjuvant endocrine therapy among hormone receptor-positive breast cancer patients in an integrated health care system. Breast Cancer Res Treat. 2018 Aug; 170(3):623-631.
    View in: PubMed
    Score: 0.353
  7. Understanding racial/ethnic differences in breast cancer-related physical well-being: the role of patient-provider interactions. Breast Cancer Res Treat. 2018 Aug; 170(3):593-603.
    View in: PubMed
    Score: 0.352
  8. Vitamin D and Breast Cancer Survival-In Reply. JAMA Oncol. 2017 08 01; 3(8):1139-1140.
    View in: PubMed
    Score: 0.336
  9. Association of Serum Level of Vitamin D at Diagnosis With Breast Cancer Survival: A Case-Cohort Analysis in the Pathways Study. JAMA Oncol. 2017 Mar 01; 3(3):351-357.
    View in: PubMed
    Score: 0.326
  10. BMI, Lifestyle Factors and Taxane-Induced Neuropathy in Breast Cancer Patients: The Pathways Study. J Natl Cancer Inst. 2017 02; 109(2).
    View in: PubMed
    Score: 0.318
  11. Representativeness of breast cancer cases in an integrated health care delivery system. BMC Cancer. 2015 Oct 14; 15:688.
    View in: PubMed
    Score: 0.296
  12. Preliminary Development and Evaluation of an Algorithm to Identify Breast Cancer Chemotherapy Toxicities Using Electronic Medical Records and Administrative Data. J Oncol Pract. 2015 01; 11(1):e1-8.
    View in: PubMed
    Score: 0.274
  13. Changes in vitamin and mineral supplement use after breast cancer diagnosis in the Pathways Study: a prospective cohort study. BMC Cancer. 2014 May 29; 14:382.
    View in: PubMed
    Score: 0.269
  14. Patient-physician interaction and quality of life in recently diagnosed breast cancer patients. Breast Cancer Res Treat. 2013 Jun; 139(2):581-95.
    View in: PubMed
    Score: 0.251
  15. Social networks, social support mechanisms, and quality of life after breast cancer diagnosis. Breast Cancer Res Treat. 2013 Jun; 139(2):515-27.
    View in: PubMed
    Score: 0.250
  16. Employment status and quality of life in recently diagnosed breast cancer survivors. Psychooncology. 2013 Jun; 22(6):1411-20.
    View in: PubMed
    Score: 0.238
  17. Validation of AJCC TNM staging for breast tumors diagnosed before 2004 in cancer registries. Cancer Causes Control. 2012 Sep; 23(9):1587-91.
    View in: PubMed
    Score: 0.237
  18. Change in physical activity during active treatment in a prospective study of breast cancer survivors. Breast Cancer Res Treat. 2012 Jan; 131(2):679-90.
    View in: PubMed
    Score: 0.224
  19. Associations of physical activity with quality of life and functional ability in breast cancer patients during active adjuvant treatment: the Pathways Study. Breast Cancer Res Treat. 2011 Sep; 129(2):521-9.
    View in: PubMed
    Score: 0.217
  20. Risk factors for lymphedema in a prospective breast cancer survivorship study: the Pathways Study. Arch Surg. 2010 Nov; 145(11):1055-63.
    View in: PubMed
    Score: 0.210
  21. Quality of life among women recently diagnosed with invasive breast cancer: the Pathways Study. Breast Cancer Res Treat. 2010 Sep; 123(2):507-24.
    View in: PubMed
    Score: 0.200
  22. Complementary and alternative therapy use before and after breast cancer diagnosis: the Pathways Study. Breast Cancer Res Treat. 2009 Oct; 117(3):653-65.
    View in: PubMed
    Score: 0.186
  23. The Pathways Study: a prospective study of breast cancer survivorship within Kaiser Permanente Northern California. Cancer Causes Control. 2008 Dec; 19(10):1065-76.
    View in: PubMed
    Score: 0.177
  24. Lifestyle factors and survival in women with breast cancer. J Nutr. 2007 01; 137(1 Suppl):236S-242S.
    View in: PubMed
    Score: 0.161
  25. Physical activity and incident cardiovascular disease in breast cancer survivors: the Pathways Study. JNCI Cancer Spectr. 2025 Jan 03; 9(1).
    View in: PubMed
    Score: 0.140
  26. Adherence to cardiovascular medications and risk of cardiovascular disease in breast cancer patients: A causal inference approach in the Pathways Heart Study. PLoS One. 2024; 19(9):e0310531.
    View in: PubMed
    Score: 0.138
  27. The landscape of use of NCCN-guideline chemotherapy regimens in stage I-IIIA breast cancer in an integrated healthcare delivery system. Breast Cancer Res Treat. 2024 Nov; 208(2):405-414.
    View in: PubMed
    Score: 0.137
  28. Trends in chemotherapy use for early-stage breast cancer from 2006 to 2019. Breast Cancer Res. 2024 Jun 13; 26(1):101.
    View in: PubMed
    Score: 0.135
  29. Methodology for Using Real-World Data From Electronic Health Records to Assess Chemotherapy Administration in Women With Breast Cancer. JCO Clin Cancer Inform. 2024 Apr; 8:e2300209.
    View in: PubMed
    Score: 0.133
  30. Diet quality and cardiovascular disease risk among breast cancer survivors in the Pathways Study. JNCI Cancer Spectr. 2024 Feb 29; 8(2).
    View in: PubMed
    Score: 0.132
  31. Risk of adverse birth outcomes after adolescent and young adult cancer. JNCI Cancer Spectr. 2024 Jan 04; 8(1).
    View in: PubMed
    Score: 0.131
  32. A Mendelian Randomization Analysis of 55 Genetically Predicted Metabolic Traits with Breast Cancer Survival Outcomes in the Pathways Study. Cancer Res Commun. 2023 06; 3(6):1104-1112.
    View in: PubMed
    Score: 0.126
  33. Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer. Breast Cancer Res Treat. 2023 Aug; 201(1):117-126.
    View in: PubMed
    Score: 0.126
  34. Comparison of Mammography AI Algorithms with a Clinical Risk Model for 5-year Breast Cancer Risk Prediction: An Observational Study. Radiology. 2023 06; 307(5):e222733.
    View in: PubMed
    Score: 0.126
  35. Neighborhood attributes and cardiovascular disease risk in breast cancer survivors: The Pathways Study. Cancer. 2023 08 01; 129(15):2395-2408.
    View in: PubMed
    Score: 0.125
  36. Results and lessons from dual extraction of DNA and RNA from formalin-fixed paraffin-embedded breast tumor tissues for a large Cancer epidemiologic study. BMC Genomics. 2022 Aug 25; 23(1):614.
    View in: PubMed
    Score: 0.119
  37. Telehealth for Preoperative Evaluation of Patients With Breast Cancer During the COVID-19 Pandemic. Perm J. 2022 06 29; 26(2):54-63.
    View in: PubMed
    Score: 0.118
  38. Risk of heart failure with preserved versus reduced ejection fraction in women with breast cancer. Breast Cancer Res Treat. 2022 Jun; 193(3):669-675.
    View in: PubMed
    Score: 0.116
  39. Risk of Cardiovascular Disease in Women With and Without Breast Cancer: The Pathways Heart Study. J Clin Oncol. 2022 May 20; 40(15):1647-1658.
    View in: PubMed
    Score: 0.116
  40. Modeling risks of cardiovascular and cancer mortality following a diagnosis of loco-regional breast cancer. Breast Cancer Res. 2021 09 27; 23(1):91.
    View in: PubMed
    Score: 0.112
  41. Plant-Based Dietary Patterns and Breast Cancer Recurrence and Survival in the Pathways Study. Nutrients. 2021 Sep 25; 13(10).
    View in: PubMed
    Score: 0.112
  42. Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women. Nat Commun. 2021 07 07; 12(1):4198.
    View in: PubMed
    Score: 0.110
  43. A Polygenic Risk Score for Breast Cancer in US Latinas and Latin American Women. J Natl Cancer Inst. 2020 06 01; 112(6):590-598.
    View in: PubMed
    Score: 0.102
  44. Physical activity and incidence of postmenopausal breast cancer. Epidemiology. 2000 May; 11(3):292-6.
    View in: PubMed
    Score: 0.102
  45. Distinct trajectories of moderate to vigorous physical activity and sedentary behavior following a breast cancer diagnosis: the Pathways Study. J Cancer Surviv. 2020 06; 14(3):393-403.
    View in: PubMed
    Score: 0.100
  46. Adjuvant endocrine therapy for breast cancer patients: impact of a health system outreach program to improve adherence. Breast Cancer Res Treat. 2020 Feb; 180(1):219-226.
    View in: PubMed
    Score: 0.100
  47. Serum bone markers and risk of osteoporosis and fragility fractures in women who received endocrine therapy for breast cancer: a prospective study. Breast Cancer Res Treat. 2020 Feb; 180(1):187-195.
    View in: PubMed
    Score: 0.099
  48. Is Breast Cancer in Asian and Asian American Women a Different Disease? J Natl Cancer Inst. 2019 12 01; 111(12):1243-1244.
    View in: PubMed
    Score: 0.099
  49. Distinct trajectories of fruits and vegetables, dietary fat, and alcohol intake following a breast cancer diagnosis: the Pathways Study. Breast Cancer Res Treat. 2020 Jan; 179(1):229-240.
    View in: PubMed
    Score: 0.098
  50. Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy. Breast Cancer Res Treat. 2018 Apr; 168(2):523-530.
    View in: PubMed
    Score: 0.086
  51. Childhood Socioeconomic Position and Pubertal Onset in a Cohort of Multiethnic Girls: Implications for Breast Cancer. Cancer Epidemiol Biomarkers Prev. 2017 12; 26(12):1714-1721.
    View in: PubMed
    Score: 0.085
  52. Genetic Ancestry Is not Associated with Breast Cancer Recurrence or Survival in U.S. Latina Women Enrolled in the Kaiser Permanente Pathways Study. Cancer Epidemiol Biomarkers Prev. 2017 09; 26(9):1466-1469.
    View in: PubMed
    Score: 0.084
  53. Patterns and reasons for switching classes of hormonal therapy among women with early-stage breast cancer. Cancer Causes Control. 2017 Jun; 28(6):557-562.
    View in: PubMed
    Score: 0.082
  54. Body mass index, PAM50 subtype, recurrence, and survival among patients with nonmetastatic breast cancer. Cancer. 2017 Jul 01; 123(13):2535-2542.
    View in: PubMed
    Score: 0.082
  55. Adiposity, post-diagnosis weight change, and risk of cardiovascular events among early-stage breast cancer survivors. Breast Cancer Res Treat. 2017 04; 162(3):549-557.
    View in: PubMed
    Score: 0.081
  56. Impact of Social and Built Environment Factors on Body Size among Breast Cancer Survivors: The Pathways Study. Cancer Epidemiol Biomarkers Prev. 2017 04; 26(4):505-515.
    View in: PubMed
    Score: 0.081
  57. Bone remodeling and regulating biomarkers in women at the time of breast cancer diagnosis. Breast Cancer Res Treat. 2017 02; 161(3):501-513.
    View in: PubMed
    Score: 0.080
  58. Association Between Complementary and Alternative Medicine Use and Breast Cancer Chemotherapy Initiation: The Breast Cancer Quality of Care (BQUAL) Study. JAMA Oncol. 2016 Sep 01; 2(9):1170-6.
    View in: PubMed
    Score: 0.079
  59. Exercise and Prognosis on the Basis of Clinicopathologic and Molecular Features in Early-Stage Breast Cancer: The LACE and Pathways Studies. Cancer Res. 2016 09 15; 76(18):5415-22.
    View in: PubMed
    Score: 0.078
  60. Intake of vitamins A, C, and E and postmenopausal breast cancer. The Iowa Women's Health Study. Am J Epidemiol. 1996 Jul 15; 144(2):165-74.
    View in: PubMed
    Score: 0.078
  61. A prospective cohort study of early discontinuation of adjuvant chemotherapy in women with breast cancer: the breast cancer quality of care study (BQUAL). Breast Cancer Res Treat. 2016 07; 158(1):127-138.
    View in: PubMed
    Score: 0.078
  62. Exercise and Risk of Cardiovascular Events in Women With Nonmetastatic Breast Cancer. J Clin Oncol. 2016 08 10; 34(23):2743-9.
    View in: PubMed
    Score: 0.077
  63. Breast cancer multigene testing trends and impact on chemotherapy use. Am J Manag Care. 2016 05 01; 22(5):e153-60.
    View in: PubMed
    Score: 0.077
  64. Psychosocial factors related to non-persistence with adjuvant endocrine therapy among women with breast cancer: the Breast Cancer Quality of Care Study (BQUAL). Breast Cancer Res Treat. 2016 05; 157(1):133-43.
    View in: PubMed
    Score: 0.077
  65. Breastfeeding, PAM50 tumor subtype, and breast cancer prognosis and survival. J Natl Cancer Inst. 2015 Jul; 107(7).
    View in: PubMed
    Score: 0.072
  66. Association of high obesity with PAM50 breast cancer intrinsic subtypes and gene expression. BMC Cancer. 2015 Apr 14; 15:278.
    View in: PubMed
    Score: 0.072
  67. Dietary fat and risk of breast cancer according to hormone receptor status. Cancer Epidemiol Biomarkers Prev. 1995 Jan-Feb; 4(1):11-9.
    View in: PubMed
    Score: 0.070
  68. Bone health history in breast cancer patients on aromatase inhibitors. PLoS One. 2014; 9(10):e111477.
    View in: PubMed
    Score: 0.069
  69. A multilevel model of postmenopausal breast cancer incidence. Cancer Epidemiol Biomarkers Prev. 2014 Oct; 23(10):2078-92.
    View in: PubMed
    Score: 0.068
  70. Non-initiation and early discontinuation of adjuvant trastuzumab in women with localized HER2-positive breast cancer. Breast Cancer. 2014 Nov; 21(6):780-5.
    View in: PubMed
    Score: 0.067
  71. Race and breast cancer survival by intrinsic subtype based on PAM50 gene expression. Breast Cancer Res Treat. 2014 Apr; 144(3):689-99.
    View in: PubMed
    Score: 0.066
  72. Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics. Cancer Epidemiol Biomarkers Prev. 2014 May; 23(5):714-24.
    View in: PubMed
    Score: 0.066
  73. Intrinsic subtypes from the PAM50 gene expression assay in a population-based breast cancer survivor cohort: prognostication of short- and long-term outcomes. Cancer Epidemiol Biomarkers Prev. 2014 May; 23(5):725-34.
    View in: PubMed
    Score: 0.066
  74. Racial disparities in posttraumatic stress after diagnosis of localized breast cancer: the BQUAL study. J Natl Cancer Inst. 2013 Apr 17; 105(8):563-72.
    View in: PubMed
    Score: 0.062
  75. Familial clustering of colon, breast, uterine, and ovarian cancers as assessed by family history. Genet Epidemiol. 1993; 10(4):235-44.
    View in: PubMed
    Score: 0.061
  76. Interpersonal influences and attitudes about adjuvant therapy treatment decisions among non-metastatic breast cancer patients: an examination of differences by age and race/ethnicity in the BQUAL study. Breast Cancer Res Treat. 2013 Feb; 137(3):817-28.
    View in: PubMed
    Score: 0.061
  77. Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004-2007. Breast Cancer Res Treat. 2013 Jan; 137(1):247-60.
    View in: PubMed
    Score: 0.060
  78. A survey of breast cancer physicians regarding patient involvement in breast cancer treatment decisions. Breast. 2013 Aug; 22(4):548-54.
    View in: PubMed
    Score: 0.060
  79. Noninitiation of adjuvant chemotherapy in women with localized breast cancer: the breast cancer quality of care study. J Clin Oncol. 2012 Nov 01; 30(31):3800-9.
    View in: PubMed
    Score: 0.060
  80. Dietary fat and postmenopausal breast cancer. J Natl Cancer Inst. 1992 Jul 15; 84(14):1092-9.
    View in: PubMed
    Score: 0.059
  81. Non-initiation of adjuvant hormonal therapy in women with hormone receptor-positive breast cancer: The Breast Cancer Quality of Care Study (BQUAL). Breast Cancer Res Treat. 2012 Jul; 134(1):419-28.
    View in: PubMed
    Score: 0.058
  82. The Breast Cancer Quality of Care Study (BQUAL): a multi-center study to determine causes for noncompliance with breast cancer adjuvant therapy. Breast J. 2012 May-Jun; 18(3):203-13.
    View in: PubMed
    Score: 0.058
  83. Antioxidant supplement use after breast cancer diagnosis and mortality in the Life After Cancer Epidemiology (LACE) cohort. Cancer. 2012 Apr 15; 118(8):2048-58.
    View in: PubMed
    Score: 0.056
  84. Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer. Breast Cancer Res Treat. 2012 Jan; 131(2):607-17.
    View in: PubMed
    Score: 0.056
  85. Multivitamin use and breast cancer outcomes in women with early-stage breast cancer: the Life After Cancer Epidemiology study. Breast Cancer Res Treat. 2011 Nov; 130(1):195-205.
    View in: PubMed
    Score: 0.054
  86. A practical method for collecting food record data in a prospective cohort study of breast cancer survivors. Am J Epidemiol. 2010 Dec 01; 172(11):1315-23.
    View in: PubMed
    Score: 0.052
  87. Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study. J Clin Oncol. 2010 Oct 10; 28(29):4410-6.
    View in: PubMed
    Score: 0.052
  88. Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat. 2011 Apr; 126(2):529-37.
    View in: PubMed
    Score: 0.052
  89. Breast cancer DNA methylation profiles are associated with tumor size and alcohol and folate intake. PLoS Genet. 2010 Jul 29; 6(7):e1001043.
    View in: PubMed
    Score: 0.052
  90. Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol. 2010 Sep 20; 28(27):4120-8.
    View in: PubMed
    Score: 0.051
  91. Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors. Breast Cancer Res. 2009; 11(3):R31.
    View in: PubMed
    Score: 0.048
  92. Dietary patterns and breast cancer recurrence and survival among women with early-stage breast cancer. J Clin Oncol. 2009 Feb 20; 27(6):919-26.
    View in: PubMed
    Score: 0.046
  93. Aspects of the rationale for the Women's Health Trial. J Natl Cancer Inst. 1988 Aug 03; 80(11):802-14.
    View in: PubMed
    Score: 0.045
  94. Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst. 2008 Apr 16; 100(8):597-8; author reply 599.
    View in: PubMed
    Score: 0.044
  95. Dietary patterns and breast density in the Minnesota Breast Cancer Family Study. Cancer Causes Control. 2008 Jun; 19(5):481-9.
    View in: PubMed
    Score: 0.043
  96. Mediterranean diet and breast density in the Minnesota Breast Cancer Family Study. Nutr Cancer. 2008; 60(6):703-9.
    View in: PubMed
    Score: 0.043
  97. Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence. J Clin Oncol. 2006 Nov 20; 24(33):e49-50.
    View in: PubMed
    Score: 0.040
  98. Body size changes in relation to postmenopausal breast cancer among women on Long Island, New York. Am J Epidemiol. 2005 Aug 01; 162(3):229-37.
    View in: PubMed
    Score: 0.036
  99. Dietary fat and cancer. Am J Med. 2002 Dec 30; 113 Suppl 9B:63S-70S.
    View in: PubMed
    Score: 0.031
  100. Interaction of dietary folate intake, alcohol, and risk of hormone receptor-defined breast cancer in a prospective study of postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2002 Oct; 11(10 Pt 1):1104-7.
    View in: PubMed
    Score: 0.030
  101. Meat and dairy food consumption and breast cancer: a pooled analysis of cohort studies. Int J Epidemiol. 2002 Feb; 31(1):78-85.
    View in: PubMed
    Score: 0.029
  102. High-folate diets and breast cancer survival in a prospective cohort study. Nutr Cancer. 2002; 44(2):139-44.
    View in: PubMed
    Score: 0.028
  103. Population-based case-control study of soyfood intake and breast cancer risk in Shanghai. Br J Cancer. 2001 Aug 03; 85(3):372-8.
    View in: PubMed
    Score: 0.028
  104. Dietary folate intake, alcohol, and risk of breast cancer in a prospective study of postmenopausal women. Epidemiology. 2001 Jul; 12(4):420-8.
    View in: PubMed
    Score: 0.028
  105. Types of dietary fat and breast cancer: a pooled analysis of cohort studies. Int J Cancer. 2001 Jun 01; 92(5):767-74.
    View in: PubMed
    Score: 0.027
  106. Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol Biomarkers Prev. 2001 May; 10(5):483-8.
    View in: PubMed
    Score: 0.027
  107. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol. 2000 Sep 15; 152(6):514-27.
    View in: PubMed
    Score: 0.026
  108. Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai Breast Cancer Study. Int J Cancer. 2000 Jul 15; 87(2):295-300.
    View in: PubMed
    Score: 0.026
  109. Twinship and risk of postmenopausal breast cancer. J Natl Cancer Inst. 2000 Feb 02; 92(3):261-5.
    View in: PubMed
    Score: 0.025
  110. Association of diet and mammographic breast density in the Minnesota breast cancer family cohort. Cancer Epidemiol Biomarkers Prev. 2000 Feb; 9(2):151-60.
    View in: PubMed
    Score: 0.025
  111. Fifty-year follow-up of cancer incidence in a historical cohort of Minnesota breast cancer families. Cancer Epidemiol Biomarkers Prev. 1999 Dec; 8(12):1051-7.
    View in: PubMed
    Score: 0.025
  112. Inclusion of risk factor covariates in a segregation analysis of a population-based sample of 426 breast cancer families. Genet Epidemiol. 1999; 16(2):150-64.
    View in: PubMed
    Score: 0.023
  113. Well-done meat intake and the risk of breast cancer. J Natl Cancer Inst. 1998 Nov 18; 90(22):1724-9.
    View in: PubMed
    Score: 0.023
  114. The role of hormone replacement therapy in the risk for breast cancer and total mortality in women with a family history of breast cancer. Ann Intern Med. 1997 Dec 01; 127(11):973-80.
    View in: PubMed
    Score: 0.021
  115. Non-dietary factors as risk factors for breast cancer, and as effect modifiers of the association of fat intake and risk of breast cancer. Cancer Causes Control. 1997 Jan; 8(1):49-56.
    View in: PubMed
    Score: 0.020
  116. Evaluation of potential sources of bias in a genetic epidemiologic study of breast cancer. Genet Epidemiol. 1997; 14(1):85-95.
    View in: PubMed
    Score: 0.020
  117. Segregation analysis of breast cancer: a comparison of type-dependent age-at-onset versus type-dependent susceptibility models. Genet Epidemiol. 1996; 13(4):317-28.
    View in: PubMed
    Score: 0.019
  118. Better breast cancer survival for postmenopausal women who are less overweight and eat less fat. The Iowa Women's Health Study. Cancer. 1995 Jul 15; 76(2):275-83.
    View in: PubMed
    Score: 0.018
  119. Epidemiologic and genetic follow-up study of 544 Minnesota breast cancer families: design and methods. Genet Epidemiol. 1995; 12(4):417-29.
    View in: PubMed
    Score: 0.018
  120. Familial clustering of breast and prostate cancers and risk of postmenopausal breast cancer. J Natl Cancer Inst. 1994 Dec 21; 86(24):1860-5.
    View in: PubMed
    Score: 0.018
  121. Dietary predictors of urinary environmental biomarkers in young girls, BCERP, 2004-7. Environ Res. 2014 Aug; 133:12-9.
    View in: PubMed
    Score: 0.017
  122. Association of body fat distribution and family histories of breast and ovarian cancer with risk of postmenopausal breast cancer. Am J Epidemiol. 1993 Nov 15; 138(10):799-803.
    View in: PubMed
    Score: 0.016
  123. No association between caffeine intake and postmenopausal breast cancer incidence in the Iowa Women's Health Study. Am J Epidemiol. 1993 Sep 15; 138(6):380-3.
    View in: PubMed
    Score: 0.016
  124. Difficulty becoming pregnant and family history as interactive risk factors for postmenopausal breast cancer: the Iowa Women's Health Study. Cancer Causes Control. 1993 Jan; 4(1):21-8.
    View in: PubMed
    Score: 0.015
  125. Effect of family history, body-fat distribution, and reproductive factors on the risk of postmenopausal breast cancer. N Engl J Med. 1992 May 14; 326(20):1323-9.
    View in: PubMed
    Score: 0.015
  126. Feasibility of a randomized trial of a low-fat diet for the prevention of breast cancer: dietary compliance in the Women's Health Trial Vanguard Study. Prev Med. 1990 Mar; 19(2):115-33.
    View in: PubMed
    Score: 0.013
  127. Association of childhood and adolescent anthropometric factors, physical activity, and diet with adult mammographic breast density. Am J Epidemiol. 2007 Aug 15; 166(4):456-64.
    View in: PubMed
    Score: 0.010

© 2025 Kaiser Permanente